Skip to main content
    C

    CVS Health Corp (CVS)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $88.60
    -0.75 (-0.84%)

    Market Cap: $114.32B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CVS Health Corp (CVS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    CVS Health reported revenue of $402.07B for the fiscal year ended Dec 31, 2025, up 7.8% from the year before. That year, net income was $1.73B with a net margin of 0.4%, operating cash flow was $10.64B and free cash flow was $7.81B. The quarter ended Sep 30, 2026 had revenue of $108.40B and net income of $2.17B.

    Revenue and Margins

    The operating margin was 1.2% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $177.55B, a compound annual rate of 9.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$402.07B+7.8%45.0%1.2%0.4%
    Dec 2024$372.81B+4.2%44.7%2.3%1.2%
    Dec 2023$357.78B+10.9%39.3%3.8%2.3%
    Dec 2022$322.47B+10.4%38.9%2.5%1.3%
    Dec 2021$292.11B+8.7%17.8%4.6%2.7%
    Dec 2020$268.71B+4.6%18.3%5.2%2.7%
    Dec 2019$256.78B+32.0%17.7%4.7%2.6%
    Dec 2018$194.58B+5.3%16.2%2.1%-0.3%
    Dec 2017$184.79B+4.1%15.4%5.2%3.6%
    Dec 2016$177.55BN/A17.5%5.8%3.0%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 62.3% from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$402.07B$372.81B$357.78B$322.47B$292.11B$268.71B$256.78B$194.58B$184.79B$177.55B
    Cost of revenue$221.17B$206.29B$217.10B$196.89B$239.99B$219.66B$211.25B$163.04B$156.26B$146.53B
    Gross profit$180.90B$166.52B$140.68B$125.58B$52.12B$49.05B$45.53B$31.54B$28.53B$31.01B
    Operating income$4.66B$8.52B$13.74B$7.95B$13.31B$13.91B$11.99B$4.02B$9.54B$10.39B
    Net income$1.73B$4.59B$8.37B$4.33B$7.99B$7.19B$6.63B-$596.00M$6.62B$5.32B
    EBITDA$9.38B$13.21B$18.20B$12.35B$17.98B$18.56B$16.48B$6.74B$11.81B$12.83B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$108.40B$106.10B$100.43B$105.69B$102.87B$98.92B$94.59B$97.71B$95.43B$91.23B$88.44B$93.81B
    Gross profit$47.21B$47.23B$44.98B$46.63B$45.83B$44.91B$43.53B$42.44B$42.48B$41.24B$40.36B$56.84B
    Operating income$3.57B$4.70B$4.68B$2.11B-$3.21B$2.38B$3.37B$2.37B$832.00M$3.04B$2.27B$3.37B
    Net income$2.17B$3.00B$2.96B$2.92B-$3.99B$1.01B$1.78B$1.62B$71.00M$1.77B$1.12B$2.05B
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $64.57B exceeded cash and equivalents by $56.12B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$253.54B$253.22B$249.73B$228.28B$233.00B$230.72B$222.45B$196.46B$95.13B$94.46B
    Current assets$74.71B$68.64B$67.86B$65.63B$60.01B$56.37B$50.30B$45.24B$31.23B$31.04B
    Cash and equivalents$8.45B$8.59B$8.20B$12.95B$9.41B$7.85B$5.68B$4.06B$1.70B$3.37B
    Total liabilities$178.16B$177.49B$173.09B$156.51B$157.62B$161.01B$158.28B$137.91B$57.44B$57.63B
    Short-term debt$4.07B$5.74B$2.97B$1.78B$4.21B$5.44B$3.78B$1.99B$4.82B$1.92B
    Long-term debt$60.50B$60.53B$58.64B$50.48B$51.97B$59.21B$64.70B$71.44B$22.18B$25.61B
    Shareholder equity$75.21B$75.56B$76.46B$71.47B$75.08B$69.39B$63.86B$58.23B$37.69B$36.83B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$258.07B$253.77B$252.97B$261.06B$255.33B$258.34B$255.59B$253.22B$252.43B$252.48B$249.74B$249.73B
    Total liabilities$177.39B$173.87B$175.34B$185.68B$182.22B$180.79B$178.47B$177.49B$177.32B$177.37B$175.59B$173.09B
    Cash and equivalents$11.74B$11.33B$9.54B$8.51B$9.10B$11.79B$10.08B$8.59B$6.88B$12.51B$9.80B$8.20B
    Shareholder equity$80.50B$79.70B$77.46B$75.21B$72.93B$77.38B$76.93B$75.56B$74.94B$74.93B$73.97B$76.46B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 73.4% of operating cash flow. Dividends came to 43.5% of it, with no share repurchases.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$10.64B$9.11B$13.43B$16.18B$18.27B$15.87B$12.85B$8.87B$8.01B$10.14B
    Capital expenditures$2.83B$2.78B$3.03B$2.73B$2.52B$2.44B$2.46B$2.04B$1.92B$2.22B
    Free cash flow$7.81B$6.33B$10.39B$13.45B$15.74B$13.43B$10.39B$6.83B$6.09B$7.92B
    Dividends paid$3.40B$3.37B$3.13B$2.91B$2.63B$2.62B$2.60B$2.04B$2.05B$1.88B
    Share repurchases$0$3.02B$2.01B$3.50B$0$0N/AN/A$4.36B$4.46B
    Investing cash flow-$5.87B-$7.61B-$20.89B-$5.05B-$5.26B-$5.53B-$3.34B-$43.28B-$2.88B-$2.47B
    Financing cash flow-$4.94B-$1.14B$2.68B-$10.52B-$11.36B-$7.70B-$7.65B$36.82B-$6.75B-$6.76B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$4.72B$6.34B$4.25B$3.39B$796.00M$1.90B$4.56B$1.86B-$745.00M$3.09B$4.90B-$2.64B
    Capital expenditures$817.00M$691.00M$849.00M$784.00M$698.00M$607.00M$743.00M$768.00M$670.00M$638.00M$705.00M$911.00M
    Free cash flow$3.91B$5.65B$3.40B$2.61B$98.00M$1.29B$3.81B$1.09B-$1.42B$2.45B$4.20B-$3.55B
    Last 12 quarters

    Frequently Asked Questions About CVS

    What is CVS Health's annual revenue?

    CVS Health reported revenue of $402.07B for the fiscal year ended Dec 31, 2025.

    How fast is CVS Health's revenue growing?

    Revenue was up 7.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 7.6%.

    Is CVS Health profitable?

    Yes. CVS Health reported net income of $1.73B for the fiscal year ended Dec 31, 2025, with a net margin of 0.4%.

    How much free cash flow does CVS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $10.64B minus capital expenditures of $2.83B produced free cash flow of $7.81B.

    How much debt does CVS Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $60.50B, short-term debt of $4.07B and cash and equivalents of $8.45B.